Monthly Archives: April 2022
Deep submucosal invasion is not an independent risk factor for lymph node metastasis in T1 colorectal cancer: a meta-analysis
Deep submucosal invasion (DSI) is considered a key risk factor for lymph node metastasis (LNM) and important criterion to recommend surgery in T1 colorectal cancer (CRC). However, metastatic risk for DSI is shown to be low in absence of other histologi… Continue reading
Proactive therapeutic drug monitoring of adalimumab in patients with Crohn’s disease
Stopping Surveillance in GI Conditions: Thoughts on the scope of the problem and potential solutions
SERENE CD: Finding serenity amid the clamour
Strengths and weaknesses of an artificial intelligence polyp detection program as assessed by a high detecting endoscopist
Correspondence: Failure to Achieve Target Drug Concentrations During Induction and Not HLA- DQA1*05 Carriage is Associated with Anti-Drug Antibody Formation in Patients with Inflammatory Bowel Disease – Is HLADQA1*05 gone before it’s here?
Correction
Bolton C, Smillie CS, Pandey S, et al. An Integrated Taxonomy for Monogenic Inflammatory Bowel Disease. Gastroenterology 2022;162:859–876. Continue reading
Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients with Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery
Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study
To identify gut and oral metagenomic signatures that accurately predict pancreatic ductal carcinoma (PDAC) and to validate these signatures in independent cohorts. Continue reading
Small Intestinal Bacterial Overgrowth, Pathophysiology and its implications for Definition and Management
The concept of small intestinal bacterial overgrowth (SIBO) arose in the context of maldigestion and malabsorption among patients with obvious risk factors that permitted the small bowel to be colonized by potentially injurious colonic microbiota. Such… Continue reading